The New England Journal of Medicine

Ph-Positive Acute Lymphoblastic Leukemia — 25 Years of Progress

In the past 25 years — from 2000 to 2024 — we have witnessed a revolution in the management, treatment, and outcome of what used to be the most lethal hematologic cancer: Philadelphia ...